Hematopoietic Stem Cells

Pediatrics

Volumn 113, Issue 4 II, 2004, Pages 1051-1057

  Trigg, Michael E ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Aplastic anemia; Pediatrics; Stem cell transplantation

Indexed keywords

ANDROGEN; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENVIRONMENTAL CHEMICAL; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

AGE; APLASTIC ANEMIA; BLOOD DONOR; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CHILD; CONVALESCENCE; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HAZARD; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; MATURATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; RISK; UMBILICAL CORD BLOOD;

ANEMIA, APLASTIC; ANTINEOPLASTIC AGENTS; BUSULFAN; CHILD; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTES; NEUTROPENIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY;

EID: 1842534292     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Thomas ED. Bone marrow transplantation: a review. Semin Hematol. 1999;36:95-103
2. Young NS. Acquired aplastic anemia. JAMA. 1999;282:271-278
3. Storb R. A plastic anemia. J Intraven Nurs. 1997;20:317-311
4. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534-546
5. Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA. 2001;285:3130-3133
6. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood. 1987;69:369-380
7. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant. 1993;12:387-398
8. Foot ABM, Potter MN, Donaldson C, et al. Immune reconstitution after BMT in children. Bone Marrow Transplant. 1993;11:7-13
9. Kook H, Goldman F, Padley D, et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood. 1996;88:1089-1097
10. Kook H, Goldman F, Giller R, et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Innnunol. 1997;4:96-103
11. Hochberg EP, Chillemi AC, Wu CJ, et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood. 2001;98:1116-1121
12. MacKintosh FR, Adlish J, Hall SW, et al. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol. 1993;21:243
13. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood. 2002;100:804-812
14. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577
15. Corn BW, Goldwein JW, Evans I, D'Angio GL. Outcomes in low-risk babies treated with half dose chemotherapy according to the 3rd National Wilms' Tumor Study. J Clin Oncol. 1992;10:1305-1309
16. Reaman GH. Special considerations for the infant with cancer. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott; 1989:263-274
17. Levie NS, deKraker J, Bökkerink JPM, Appel IM, Aronson DC. SIOP treatment guidelines for renal tumours in small infants: fact or fantasy? Eur J Surg Oncol. 2000;26:567-570
18. Besa EC, Woermann U, Davis TH, et al. Bone marrow failure. e-Medicine. Available at: www.emedicine.com/MED/topic235.htm
19. Vassel G, Gouyette A, Hartmann O, et al. Pharmacokinetics of high-dose Busulfan in children. Cancer Chemother Pharmacol. 1989;24:386-390
20. Regazzi MB, Locatelli F, Buggia I, et al. Disposition of high dose Busulfan in pediatric patients undergoing bone marrow transplantation. Clin Pharmacol Ther. 1993;54:45-52
21. Bolinger MA, Zangwill AB, Slattery JT, et al. Evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease. Bone Marrow Transplant. 2000;25:925-930